- Research Article
1
- 10.1016/j.pmatsci.2025.101644
Nanoplatform-Guided modulation of organelle dynamics: mechanistic insights and therapeutic strategies
- Apr 01, 2026
- Progress in Materials Science
- Yanqi Chen + 12 more +12
Publications from 2021 to 2026
Showing 10 of 175 papers
Nanoplatform-Guided modulation of organelle dynamics: mechanistic insights and therapeutic strategies
Ductility and hydration mechanisms of innovative engineered/strain-hardening cementitious composites (ECC/SHCC) incorporating solid-waste-derived binder
SLP-76/LAT AND-gated CAR-T cells mediate highly specific and durable antitumor activity in pancreatic ductal adenocarcinoma with reduced gastric toxicity
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive human malignancies, characterized by a five-year survival rate of approximately 13 percent and limited therapeutic efficacy. Although Claudin18.2 (CLDN18.2)-directed chimeric antigen receptor (CAR) T cells have demonstrated promising antitumor activity, physiological CLDN18.2 expression in normal gastric epithelium poses a risk of severe on-target, off-tumor toxicity. Methods An AND-gated CAR platform incorporating LAT and SLP-76 signaling modules was generated to restrict T-cell activation to concurrent recognition of CLDN18.2 and Mesothelin (MSLN). Antitumor efficacy, specificity, and safety were evaluated using PDAC cell lines and murine PDAC xenograft models. Durability-associated transcriptional programs and functional stability were assessed by transcriptomic profiling with quantitative PCR validation and multi-round killing assays. Results The AND-gated CAR-T cells exhibited stringent antigen dependency, selectively eliminating dual-antigen-positive tumor cells while sparing single-antigen or low antigen density targets. In addition, transcriptomic profiling revealed enrichment of memory- and durability-associated programs in AND-gated CAR-T cells, which was supported by increased expression of C-X-C motif chemokine receptor 6 (CXCR6), interleukin-7 receptor (IL7R), and C-C motif chemokine ligand 5 (CCL5), along with reduced expression of interleukin-2 receptor alpha (IL2RA) and nuclear receptor subfamily 4 group A member 1 (NR4A1) in both CD4⁺ and CD8⁺ subsets. Consistent with this profile, AND-gated CAR-T cells maintained cytotoxic activity across repeated antigen challenges, whereas conventional CLDN18.2 CAR-T cells exhibited progressive functional decline. Importantly, in murine PDAC models, AND-gated CAR-T cells achieved pronounced tumor regression while preserving gastric tissue integrity and without overt toxicity, corroborating their translational potential. Conclusions These findings demonstrate that AND-gated CLDN18.2&MSLN CAR-T cells achieve tumor-restricted cytotoxicity in PDAC while exhibiting durable antitumor function and transcriptional programs associated with T-cell functional stability, supporting AND-gated CAR-T strategies to improve the safety and durability of CAR-T therapy in solid tumors.
Read moreInositol and Berberine Synergistically Reprogram Endocrine and Ovarian Metabolism in Polycystic Ovary Syndrome.
Although Myo-Inositol/D-Chiro-Inositol (Ins) and berberine (BBR) have each shown beneficial effects in polycystic ovary syndrome (PCOS), their combined therapeutic potential has not been systematically evaluated. Here, we demonstrate that Ins/BBR exerts superior efficacy compared with single treatments by targeting multiple pathogenic pathways in PCOS. In a DHEA+HFD-induced mouse model, Ins/BBR restored systemic sex steroid balance, normalized LH/FSH ratio, and improved estrous cyclicity. It also reduced ovarian cysts and enhanced fertility, accompanied by partial normalization of steroidogenic enzyme expression. At the cellular level, Ins/BBR alleviated mitochondrial defects and broadly reprogrammed metabolic landscape in granulosa cells, in specific, restoring nucleotide pools and amino acid turnover and preventing abnormal long-chain fatty acid accumulation. Together, these findings provide preclinical evidence that Ins/BBR acts through coordinated endocrine, ovarian and metabolic mechanisms, supporting its promise as a safe and effective therapeutic strategy for PCOS.
Read moreCorrelation analysis reveals that umbilical cord diameter and farrowing duration affect the reproductive performance of sows
This study evaluated the relationships between sow parity, prepartum faecal score, farrowing and umbilical cord traits, and reproductive performance. Data were obtained from sows of different parities on commercial farms with records of litter characteristics, farrowing intervals and duration, prepartum faecal scores, and umbilical cord artery and vein diameters. Fourth- and sixth-parity sows produced more total piglets and live-born healthy piglets than first-parity sows, while piglets born to second- to fourth-parity sows had higher live birthweights. Parity did not influence the number of piglets born weak or perinatal mortality rates. Faecal scores of 3.00–3.99 and >4.00 three days prepartum were associated with increased numbers of healthy piglets and reduced numbers of stillborn piglets. Short farrowing intervals (<10 minutes) were numerically associated with higher numbers of live-born piglets and fewer stillborn piglets per litter, although these differences were not statistically significant, and a tendency towards an increased number of piglets born weak was observed. Prolonged farrowing duration was associated with increased perinatal mortality. A higher umbilical cord vein diameter was associated with increased live birthweights and fewer piglets born weak, whereas umbilical artery diameter showed no clear association with reproductive performance. Stillbirths tended to increase with umbilical cord vein diameters of 3.6–4.0 mm. These results indicate that sow parity, prepartum faecal score, farrowing traits, and umbilical cord vein traits are closely associated with reproductive outcomes and perinatal mortality. Optimising gastrointestinal function during the prepartum period and improving farrowing management may contribute to enhanced piglet viability and birthweight. (Submitted 27 June 2023; Accepted 10 February 2026; Published 23 February 2026)
Read moreGene III Ergothioneine ameliorates alcoholic fatty liver disease: A dual strategy of accelerated ethanol elimination and reducing oxidative stress
Abstract Background Alcoholic fatty liver disease (AFLD) is a progressive hepatic pathology triggered by chronic ethanol consumption, serving as the initial stage of severe liver injury. Currently, there are no FDA-approved pharmacological interventions that specifically target alcohol-induced hepatic steatosis or prevent disease progression, highlighting an urgent need for effective preventive strategies. This study evaluated the preventive efficacy and underlying mechanisms of Gene III Ergothioneine (EGT) in a clinically relevant preclinical model. Methods C57BL/6 mice were randomized into five groups: a Control group, an alcoholic fatty liver Model group, a Positive control group treated with Silybin (100 mg/kg), and three EGT treatment groups (10, 30, and 50 mg/kg). The NIAAA mouse model was utilized to induce alcoholic fatty liver. Various biochemical, histological, and molecular markers were assessed to evaluate liver damage, alcohol metabolism, lipid profiles, oxidative stress, and inflammation. Results Gene III EGT treatment significantly ameliorated hepatic steatosis and necrosis, as confirmed by H&E and Oil Red O staining. Notably, EGT accelerated alcohol clearance, reducing serum ethanol levels by up to 54.4% in a dose-dependent manner. Furthermore, EGT restored liver function markers (ALT, AST, GGT) and corrected dyslipidemia by lowering TG, TC, and LDL-C while elevating HDL-C. Mechanistically, EGT suppressed pro-inflammatory cytokines (IL-6, IL-1 β) and mitigated oxidative stress by reducing malondialdehyde (MDA) accumulation and restoring superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities. Conclusion Gene III Ergothioneine prevents alcoholic liver injury through a dual mechanism: accelerating ethanol metabolism and enhancing hepatocyte antioxidative and anti-inflammatory defenses. These findings position EGT as a promising therapeutic candidate for AFLD management.
Read moreIdentification of the Novel HLA-DPA1*02:02:21 Allele by PolyseqOne and Oxford Nanopore Sequencing.
HLA-DPA1*02:02:21 differs from HLA-DPA1*02:02:02 by one synonymous nucleotide substitution in codon 37 in exon 2.
3D bioprinted composite scaffold incorporating microfluidics-derived chondrocyte microspheroids promotes auricular cartilage regeneration
Microtia remains a major clinical challenge, as autologous costal cartilage transplantation—the current gold standard—suffers from donor-site morbidity and imprecise morphology, whereas synthetic implants are prone to immune rejection and structural collapse. Here, we present a biphasic composite strategy integrating microfluidics and 3D bioprinting. Organoid-like auricular spheroids generated via microfluidics exhibited a biomimetic architecture, featuring cartilage-specific collagen cores surrounded by organized chondrocytes, with sustained ECM secretion and phenotype maintenance. These bioactive spheroids were subsequently incorporated into a biomimetic bioink and patterned through extrusion-based 3D bioprinting, enabling precise anatomical shaping and functional scaffold construction. Upon implantation in immunodeficient mice, the biphasic constructs promoted rapid in situ cartilage regeneration and ECM deposition, yielding tissue with morphological and histological features closely resembling native auricular cartilage. Collectively, this study demonstrates that the integration of microfluidic spheroids with 3D bioprinting offers a balanced solution between structural fidelity and biological functionality, providing a promising pathway for auricular cartilage reconstruction.
Read moreEffect of the antimicrobial peptide BmKn2-7 in inhibiting Vibrio parahaemolyticus and its role in improving microbiota, immunity and Vibrio resistance in Litopenaeus vannamei.
Antimicrobial peptide BmKn2-7, a rationally optimized derivative of the scorpion venom peptide BmKn2, shows strong potential as an antibiotic alternative for controlling Vibrio parahaemolyticus in aquaculture. This study evaluated its antibacterial mechanisms and in vivo efficacy in Litopenaeus vannamei through biochemical assays, transcriptomic profiling, and challenge experiments. BmKn2-7 exhibited potent in-vitro activity (MIC = 125 µg/mL) and disrupted bacterial homeostasis by increasing membrane permeability, inducing oxidative stress, and inhibiting P-type ATPase. RNA-seq analysis revealed extensive transcriptional reprogramming, including the downregulation of quorum-sensing, virulence, and β-lactam resistance–associated genes. In vivo, BmKn2-7 significantly improved shrimp survival following V. parahaemolyticus infection and selectively reduced Vibrio abundance in the gut without compromising overall microbiota diversity. Together, these findings demonstrate that BmKn2-7 acts through complementary bactericidal and anti-virulence pathways while promoting intestinal microbial resilience, supporting its potential as a promising antimicrobial candidate for reducing vibriosis risk in shrimp aquaculture.
Read moreOrganoid Profiler: Automated, high-throughput and quantitative morphological characterization uncovers conserved longitudinal developmental kinetics in microfluidics-engineered organoids
Abstract Three-dimensional organoid systems have emerged as transformative tools in biomedical research, yet their translation into standardized high-throughput screening platforms is impeded by stochastic fabrication variability and a lack of scalable quantitative analytics. Here, we present a unified framework integrating microfluidic droplet engineering with Organoid Profiler , an automated deep-phenotyping pipeline designed to capture longitudinal morphological kinetics. By processing over 10,000 longitudinally tracked images across murine lung and liver and human cerebral models, we show that this platform achieves human-level segmentation precision ( r = 0.99) while uncovering conserved developmental dynamics obscured in manual cultures. We identify a distinct biphasic “remodeling-to-expansion” trajectory in microfluidic organoids, characterized by an initial compaction phase underpinned by the transcriptional upregulation of focal adhesion pathways, followed by exponential expansion. We further demonstrate a “shape relaxation” phenomenon where tissues converge to spherical equilibrium regardless of initial geometry, indicating intrinsic self-organization. Multi-modal profiling confirms that microfluidic organoids exhibit superior viability, homogeneity (area variability ≤ 5% upon fabrication, ≤ 15% across development) and biological fidelity, retaining physiological levels of immune and stromal niche components often lost in conventional culture. This study establishes morphological metrics as reliable, non-invasive proxies for tissue health and molecular maturity, providing a standardized foundation for quantitative organoid biology.
Read more